Recruiting Alzheimers Disease Studies in Spokane
Study of TU2218 in Combination With KEYTRUDA®(Pembrolizumab) in Patients With Advanced Solid Tumors
This study consists of phase 1b and 2a to evaluate safety, Pharmacokinetics, and efficacy of TU2218 in combination with Pembrolizumab in patients with advanced solid tumors....
A Study Evaluating the Safety and Efficacy of HB0036 in Subjects With Advanced Solid Tumors
It is a Phase I/II, Open-label, Multicenter Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of HB0036 in Subjects with Advanced Solid Tumors...
About Alzheimers Disease Clinical Trials in Spokane
Alzheimer's disease is a progressive brain disorder that destroys memory, thinking skills, and the ability to carry out daily tasks. It is the most common cause of dementia, affecting over 6.7 million Americans age 65 and older. The disease is characterized by amyloid-beta plaques and tau tangles in the brain. Recent FDA approvals of anti-amyloid antibodies like lecanemab (Leqembi) and donanemab have opened a new era of disease-modifying treatments. Clinical trials are now exploring next-generation amyloid-clearing therapies, tau-targeting treatments, anti-inflammatory approaches, and combination strategies. Early-stage patients with mild cognitive impairment or early Alzheimer's are frequently sought for enrollment, and many trials now use blood-based biomarkers for screening.
There are currently 2 alzheimers disease clinical trials recruiting participants in Spokane, WASHINGTON. These studies are seeking a combined 220 participants. Research is being sponsored by TiumBio Co., Ltd., Shanghai Huaota Biopharmaceutical Co., Ltd.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Alzheimers Disease Clinical Trials in Spokane — FAQ
Are there alzheimers disease clinical trials in Spokane?
Yes, there are 2 alzheimers disease clinical trials currently recruiting in Spokane, WASHINGTON. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Spokane?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Spokane research site will contact you about next steps.
Are clinical trials in Spokane free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Spokane studies also compensate for your time and travel.
What alzheimers disease treatments are being tested?
The 2 active trials in Spokane are testing new therapies including novel drugs, biologics, and treatment approaches for alzheimers disease.
Data updated March 2, 2026 from ClinicalTrials.gov